Stock Markets May 11, 2026 04:16 AM

Victrex Cuts Staff, Lowers Profit Outlook as Middle East Cost Pressures Bite

High-performance polymer maker flags workforce reductions and reduced full-year underlying PBT amid raw material and energy cost concerns

By Marcus Reed

Victrex said it will eliminate roughly 10% of roles, primarily within central functions, and now expects full-year underlying profit before tax of between 42 million and 44 million, below the H1 run-rate implication. The company cited rising raw material and energy costs tied to the Middle East conflict as a key factor shaping the outlook.

Victrex Cuts Staff, Lowers Profit Outlook as Middle East Cost Pressures Bite

Key Points

  • Victrex will cut about 10% of its workforce, mainly in central functions, with most departures expected in Q3.
  • Full-year underlying profit before tax is now guided to 4244 million, below the H1 implied 46.2 million.
  • H1 underlying PBT fell 18% to 19 million; a 60.6 million impairment at Panjin produced a reported loss before tax of 4 million.

Victrex shares fell more than 4% on Monday after the Lancashire-based polymer specialist announced a reduction in headcount and a lower full-year profit forecast. The group said it will remove approximately 10% of its workforce, concentrated mainly in central functions, and set a new underlying profit before tax range of 42 million to 44 million for the full year - below the 46.2 million that H1's run-rate implied.

The job reductions are part of a Profit Improvement Plan, with most departures expected to occur during the third quarter. Management says early benefits from these changes are anticipated by the end of the second half of 2026, with more substantial savings expected in the full year 2027.

Chief Executive James Routh commented on the external pressures: "We are mindful of the potential implications for global demand and energy costs given the ongoing events in the Middle East," and said the group was "reflecting the expected impact of this in pricing discussions with customers."

For the six months ended 31 March 2026, underlying profit before tax declined 18% to 19 million. A non-cash impairment charge of 60.6 million related to the Panjin, China manufacturing site turned the reported position into a loss before tax of 4 million, compared with a profit of 7.2 million a year earlier.

Group revenue edged up 1% to 147.1 million, supported by a 6% rise in sales volumes to 2,137 tonnes. The company reported a 4% decline in average selling price year-on-year to 69 per kilogram.

Profitability indicators weakened in the period: gross margin compressed to 41.7% from 44.1% and basic loss per share moved to 37.0 pence, compared with earnings of 17.4 pence in H1 2025.

On a divisional basis, medical revenues fell 9% to 7.6 million, while the Sustainable Solutions division saw revenue increase 3% to 19.5 million.

Exceptional items in the half totalled 3 million. Management also signalled an additional non-cash charge of up to 10 million in H2 2026 associated with portfolio simplification, leaving full-year exceptional items expected to be between 5 million and 85 million.

Financial position metrics included net debt of 45.4 million and a net debt to underlying EBITDA ratio of 0.65 times. The interim dividend was maintained at 13.42 pence per share, payable on 26 June 2026.

Risks

  • Rising raw material and energy costs tied to the Middle East conflict could further pressure margins and pricing discussions - impacting materials and industrial sectors.
  • Output at the Panjin manufacturing facility remains constrained by a process technology fault, which has led to a non-cash impairment and reduced effective capacity - posing manufacturing and supply risks for the company.
  • Exceptional and restructuring charges, including a guided non-cash charge up to  million in H2 2026, create uncertainty for near-term reported earnings and cash allocations.

More from Stock Markets

Nvidia CEO Jensen Huang Sees 27% Drop in Total Pay as Stock Awards Lose Value May 12, 2026 Activist Urges BWX Technologies to Revisit Shelved Reactor Plan, Sees Potential for Stock to Double May 12, 2026 S&P Moves Mexico’s Outlook to Negative, Citing Fiscal Strain and Tepid Growth May 12, 2026 Moody's Lowers Everforth Outlook to Negative Amid Elevated Leverage May 12, 2026 Moody's Moves Albemarle Outlook to Stable After Debt Cuts and Stronger Lithium Prices May 12, 2026